Coya Therapeutics, Inc. (NASDAQ:COYA) Financings

Coya Therapeutics, Inc.

Financings

RaiseDate
Private placement of common stock
Announced: about US$11.1M · US$4.4 a share
Buyers: Dr. Reddy’s Laboratories, Inc. ($10 million); Greenlight Capital ($1.1 million)
Use of proceeds: Accelerate tech transfer and scale-up manufacturing of low dose IL-2 to support commercial readiness of COYA 302
Jan 30, 2026
Public offering of common stock
Closed: US$23M raised · US$5.5 a share · Lucid Capital Markets +1
Dealers: Lucid Capital Markets (lead), Allele Capital Partners, LLC
Use of proceeds: Working capital and general corporate purposes, including funding its clinical development plan
Oct 27, 2025

Read by 6ix AI from the company's releases